peripheral insulin intra cellular receptor.[hide]v • d • eOral antidiabetic drugs and Insulin analogs (A10)Biguanides MetforminSulfonylureas Chlorpropamide, Glibenclamide (Glyburide), yugo amaryl Glimepiride, Glipizide, Gliquidone, Tolazamide, TolbutamideAlpha-glucosidase inhibitors Acarbose, Miglitol.

cat. ?Legal statusRoutes ?Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis. Glimepiride yugo amaryl the yugo amaryl third-generation sulfonylurea, and is very potent.Contents [hide]1 Indications2 Adverse effects3 Contraindications4 Interactions5 Pharmacology6 Mechanism of actionMain article: SulfonylureaGlimepiride distinctly lower the blood glucose level by both defects of NIDDM, by stimulating pancreatic beta cells to produce more insulin and induced increased activity of peripheral insulin intra cellular receptor.[hide]v • d • eOral antidiabetic drugs and Insulin yugo amaryl yugo amaryl MetforminSulfonylureas yugo amaryl Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, TolbutamideAlpha-glucosidase inhibitors Acarbose, Miglitol, VogliboseThiazolidinediones (TZD) yugo amaryl Rivoglitazone†, Rosiglitazone, Troglitazone‡Meglitinides Nateglinide, Repaglinide, MitiglinideDipeptidyl peptidase-4.

peptide-1 analog ExenatideAmylin analog PramlintideInsulin analogs fast acting (Insulin glargine, Insulin detemir)Dual PPAR.